Global Oral Proteins and Peptides Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Corrosion Under Insulation (CUI) Monitoring market size is predicted to grow from US$ 214 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Corrosion under insulation (CUI) poses a significant operational loss, safety hazard and economic cost. Corrosion under insulation (CUI) is invisible to the surface of the insulation. Because of this, it is very difficult for conventional techniques to detect and monitor corrosion under insulation. The presence of moisture in and under insulation is the root cause of corrosion under insulation (CUI). Corrosion under insulation is a severe form of localized external corrosion that occurs in carbon and low alloy steel equipment that has been insulated. This form of corrosion occurs when water is absorbed by or collected in the insulation. As a result he equipment begins to corrode as it is exposed to water and oxygen. Depending on the structure and the location of the insulation, CUI can attack the jacketing, insulation hardware or underlying piping equipment. Additionally, when insulation becomes wet or absorbs moisture, its thermal insulating properties are drastically reduced. Because water conducts heat more efficiently than air, an aggressive corrosion cell is created where the trapped heat accelerates the rate of corrosion.
Global key players of Corrosion Under Insulation (CUI) Monitoring include Mistras, QSA Global, Inc. , Previan (Eddyfi), Kaefer Group, Alabama Specialty Products (Metal Samples) and Applied Technical Services, LLC, etc. The top six manufacturers hold a share over 65%.
LPI (LP Information)' newest research report, the “Corrosion Under Insulation (CUI) Monitoring Industry Forecast” looks at past sales and reviews total world Corrosion Under Insulation (CUI) Monitoring sales in 2024, providing a comprehensive analysis by region and market sector of projected Corrosion Under Insulation (CUI) Monitoring sales for 2025 through 2031. With Corrosion Under Insulation (CUI) Monitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corrosion Under Insulation (CUI) Monitoring industry.
This Insight Report provides a comprehensive analysis of the global Corrosion Under Insulation (CUI) Monitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corrosion Under Insulation (CUI) Monitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corrosion Under Insulation (CUI) Monitoring market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corrosion Under Insulation (CUI) Monitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corrosion Under Insulation (CUI) Monitoring.
This report presents a comprehensive overview, market shares, and growth opportunities of Corrosion Under Insulation (CUI) Monitoring market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Corrosion Under Insulation (CUI) Monitoring market size is predicted to grow from US$ 214 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Corrosion under insulation (CUI) poses a significant operational loss, safety hazard and economic cost. Corrosion under insulation (CUI) is invisible to the surface of the insulation. Because of this, it is very difficult for conventional techniques to detect and monitor corrosion under insulation. The presence of moisture in and under insulation is the root cause of corrosion under insulation (CUI). Corrosion under insulation is a severe form of localized external corrosion that occurs in carbon and low alloy steel equipment that has been insulated. This form of corrosion occurs when water is absorbed by or collected in the insulation. As a result he equipment begins to corrode as it is exposed to water and oxygen. Depending on the structure and the location of the insulation, CUI can attack the jacketing, insulation hardware or underlying piping equipment. Additionally, when insulation becomes wet or absorbs moisture, its thermal insulating properties are drastically reduced. Because water conducts heat more efficiently than air, an aggressive corrosion cell is created where the trapped heat accelerates the rate of corrosion.
Global key players of Corrosion Under Insulation (CUI) Monitoring include Mistras, QSA Global, Inc. , Previan (Eddyfi), Kaefer Group, Alabama Specialty Products (Metal Samples) and Applied Technical Services, LLC, etc. The top six manufacturers hold a share over 65%.
LPI (LP Information)' newest research report, the “Corrosion Under Insulation (CUI) Monitoring Industry Forecast” looks at past sales and reviews total world Corrosion Under Insulation (CUI) Monitoring sales in 2024, providing a comprehensive analysis by region and market sector of projected Corrosion Under Insulation (CUI) Monitoring sales for 2025 through 2031. With Corrosion Under Insulation (CUI) Monitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corrosion Under Insulation (CUI) Monitoring industry.
This Insight Report provides a comprehensive analysis of the global Corrosion Under Insulation (CUI) Monitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corrosion Under Insulation (CUI) Monitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corrosion Under Insulation (CUI) Monitoring market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corrosion Under Insulation (CUI) Monitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corrosion Under Insulation (CUI) Monitoring.
This report presents a comprehensive overview, market shares, and growth opportunities of Corrosion Under Insulation (CUI) Monitoring market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Hardware
- Software
- Services
- Oil & Gas
- Marine
- Chemical & Petrochemical
- Energy & Power
- Food Processing Industries
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mistras
- QSA Global, Inc.
- Previan (Eddyfi)
- Kaefer Group
- Alabama Specialty Products (Metal Samples)
- Applied Technical Services, LLC
- Testex Inc
- Rohrback Cosasco Systems (RCS)
- 3-Sci Limited
- CorrosionRADAR
- iSensPro
- ESR Technology
- Maxwell NDT
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Proteins and Peptides Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oral Proteins and Peptides by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oral Proteins and Peptides by Country/Region, 2020, 2024 & 2031
2.2 Oral Proteins and Peptides Segment by Type
2.2.1 Linaclotide
2.2.2 Insulin
2.2.3 Plecanatide
2.2.4 Cyclosporine
2.2.5 Octreotide
2.3 Oral Proteins and Peptides Sales by Type
2.3.1 Global Oral Proteins and Peptides Sales Market Share by Type (2020-2025)
2.3.2 Global Oral Proteins and Peptides Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oral Proteins and Peptides Sale Price by Type (2020-2025)
2.4 Oral Proteins and Peptides Segment by Application
2.4.1 Gastric & Digestive Disorders
2.4.2 Bone Diseases
2.4.3 Diabetes
2.4.4 Hormonal Disorders
2.5 Oral Proteins and Peptides Sales by Application
2.5.1 Global Oral Proteins and Peptides Sale Market Share by Application (2020-2025)
2.5.2 Global Oral Proteins and Peptides Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oral Proteins and Peptides Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oral Proteins and Peptides Breakdown Data by Company
3.1.1 Global Oral Proteins and Peptides Annual Sales by Company (2020-2025)
3.1.2 Global Oral Proteins and Peptides Sales Market Share by Company (2020-2025)
3.2 Global Oral Proteins and Peptides Annual Revenue by Company (2020-2025)
3.2.1 Global Oral Proteins and Peptides Revenue by Company (2020-2025)
3.2.2 Global Oral Proteins and Peptides Revenue Market Share by Company (2020-2025)
3.3 Global Oral Proteins and Peptides Sale Price by Company
3.4 Key Manufacturers Oral Proteins and Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Proteins and Peptides Product Location Distribution
3.4.2 Players Oral Proteins and Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL PROTEINS AND PEPTIDES BY GEOGRAPHIC REGION
4.1 World Historic Oral Proteins and Peptides Market Size by Geographic Region (2020-2025)
4.1.1 Global Oral Proteins and Peptides Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oral Proteins and Peptides Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Proteins and Peptides Market Size by Country/Region (2020-2025)
4.2.1 Global Oral Proteins and Peptides Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oral Proteins and Peptides Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Proteins and Peptides Sales Growth
4.4 APAC Oral Proteins and Peptides Sales Growth
4.5 Europe Oral Proteins and Peptides Sales Growth
4.6 Middle East & Africa Oral Proteins and Peptides Sales Growth
5 AMERICAS
5.1 Americas Oral Proteins and Peptides Sales by Country
5.1.1 Americas Oral Proteins and Peptides Sales by Country (2020-2025)
5.1.2 Americas Oral Proteins and Peptides Revenue by Country (2020-2025)
5.2 Americas Oral Proteins and Peptides Sales by Type (2020-2025)
5.3 Americas Oral Proteins and Peptides Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Proteins and Peptides Sales by Region
6.1.1 APAC Oral Proteins and Peptides Sales by Region (2020-2025)
6.1.2 APAC Oral Proteins and Peptides Revenue by Region (2020-2025)
6.2 APAC Oral Proteins and Peptides Sales by Type (2020-2025)
6.3 APAC Oral Proteins and Peptides Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Proteins and Peptides by Country
7.1.1 Europe Oral Proteins and Peptides Sales by Country (2020-2025)
7.1.2 Europe Oral Proteins and Peptides Revenue by Country (2020-2025)
7.2 Europe Oral Proteins and Peptides Sales by Type (2020-2025)
7.3 Europe Oral Proteins and Peptides Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Proteins and Peptides by Country
8.1.1 Middle East & Africa Oral Proteins and Peptides Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oral Proteins and Peptides Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Proteins and Peptides Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Proteins and Peptides Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Proteins and Peptides
10.3 Manufacturing Process Analysis of Oral Proteins and Peptides
10.4 Industry Chain Structure of Oral Proteins and Peptides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Proteins and Peptides Distributors
11.3 Oral Proteins and Peptides Customer
12 WORLD FORECAST REVIEW FOR ORAL PROTEINS AND PEPTIDES BY GEOGRAPHIC REGION
12.1 Global Oral Proteins and Peptides Market Size Forecast by Region
12.1.1 Global Oral Proteins and Peptides Forecast by Region (2026-2031)
12.1.2 Global Oral Proteins and Peptides Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Proteins and Peptides Forecast by Type (2026-2031)
12.7 Global Oral Proteins and Peptides Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Ironwood & Allergan
13.1.1 Ironwood & Allergan Company Information
13.1.2 Ironwood & Allergan Oral Proteins and Peptides Product Portfolios and Specifications
13.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Ironwood & Allergan Main Business Overview
13.1.5 Ironwood & Allergan Latest Developments
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Information
13.2.2 Novo Nordisk Oral Proteins and Peptides Product Portfolios and Specifications
13.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novo Nordisk Main Business Overview
13.2.5 Novo Nordisk Latest Developments
13.3 Synergy Pharmaceuticals ?Salix?
13.3.1 Synergy Pharmaceuticals ?Salix? Company Information
13.3.2 Synergy Pharmaceuticals ?Salix? Oral Proteins and Peptides Product Portfolios and Specifications
13.3.3 Synergy Pharmaceuticals ?Salix? Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Synergy Pharmaceuticals ?Salix? Main Business Overview
13.3.5 Synergy Pharmaceuticals ?Salix? Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Oral Proteins and Peptides Product Portfolios and Specifications
13.4.3 Novartis Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Chiasma (Amryt Pharma)
13.5.1 Chiasma (Amryt Pharma) Company Information
13.5.2 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolios and Specifications
13.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chiasma (Amryt Pharma) Main Business Overview
13.5.5 Chiasma (Amryt Pharma) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Proteins and Peptides Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oral Proteins and Peptides by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oral Proteins and Peptides by Country/Region, 2020, 2024 & 2031
2.2 Oral Proteins and Peptides Segment by Type
2.2.1 Linaclotide
2.2.2 Insulin
2.2.3 Plecanatide
2.2.4 Cyclosporine
2.2.5 Octreotide
2.3 Oral Proteins and Peptides Sales by Type
2.3.1 Global Oral Proteins and Peptides Sales Market Share by Type (2020-2025)
2.3.2 Global Oral Proteins and Peptides Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oral Proteins and Peptides Sale Price by Type (2020-2025)
2.4 Oral Proteins and Peptides Segment by Application
2.4.1 Gastric & Digestive Disorders
2.4.2 Bone Diseases
2.4.3 Diabetes
2.4.4 Hormonal Disorders
2.5 Oral Proteins and Peptides Sales by Application
2.5.1 Global Oral Proteins and Peptides Sale Market Share by Application (2020-2025)
2.5.2 Global Oral Proteins and Peptides Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oral Proteins and Peptides Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oral Proteins and Peptides Breakdown Data by Company
3.1.1 Global Oral Proteins and Peptides Annual Sales by Company (2020-2025)
3.1.2 Global Oral Proteins and Peptides Sales Market Share by Company (2020-2025)
3.2 Global Oral Proteins and Peptides Annual Revenue by Company (2020-2025)
3.2.1 Global Oral Proteins and Peptides Revenue by Company (2020-2025)
3.2.2 Global Oral Proteins and Peptides Revenue Market Share by Company (2020-2025)
3.3 Global Oral Proteins and Peptides Sale Price by Company
3.4 Key Manufacturers Oral Proteins and Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Proteins and Peptides Product Location Distribution
3.4.2 Players Oral Proteins and Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL PROTEINS AND PEPTIDES BY GEOGRAPHIC REGION
4.1 World Historic Oral Proteins and Peptides Market Size by Geographic Region (2020-2025)
4.1.1 Global Oral Proteins and Peptides Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oral Proteins and Peptides Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Proteins and Peptides Market Size by Country/Region (2020-2025)
4.2.1 Global Oral Proteins and Peptides Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oral Proteins and Peptides Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Proteins and Peptides Sales Growth
4.4 APAC Oral Proteins and Peptides Sales Growth
4.5 Europe Oral Proteins and Peptides Sales Growth
4.6 Middle East & Africa Oral Proteins and Peptides Sales Growth
5 AMERICAS
5.1 Americas Oral Proteins and Peptides Sales by Country
5.1.1 Americas Oral Proteins and Peptides Sales by Country (2020-2025)
5.1.2 Americas Oral Proteins and Peptides Revenue by Country (2020-2025)
5.2 Americas Oral Proteins and Peptides Sales by Type (2020-2025)
5.3 Americas Oral Proteins and Peptides Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Proteins and Peptides Sales by Region
6.1.1 APAC Oral Proteins and Peptides Sales by Region (2020-2025)
6.1.2 APAC Oral Proteins and Peptides Revenue by Region (2020-2025)
6.2 APAC Oral Proteins and Peptides Sales by Type (2020-2025)
6.3 APAC Oral Proteins and Peptides Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Proteins and Peptides by Country
7.1.1 Europe Oral Proteins and Peptides Sales by Country (2020-2025)
7.1.2 Europe Oral Proteins and Peptides Revenue by Country (2020-2025)
7.2 Europe Oral Proteins and Peptides Sales by Type (2020-2025)
7.3 Europe Oral Proteins and Peptides Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Proteins and Peptides by Country
8.1.1 Middle East & Africa Oral Proteins and Peptides Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oral Proteins and Peptides Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Proteins and Peptides Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Proteins and Peptides Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Proteins and Peptides
10.3 Manufacturing Process Analysis of Oral Proteins and Peptides
10.4 Industry Chain Structure of Oral Proteins and Peptides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Proteins and Peptides Distributors
11.3 Oral Proteins and Peptides Customer
12 WORLD FORECAST REVIEW FOR ORAL PROTEINS AND PEPTIDES BY GEOGRAPHIC REGION
12.1 Global Oral Proteins and Peptides Market Size Forecast by Region
12.1.1 Global Oral Proteins and Peptides Forecast by Region (2026-2031)
12.1.2 Global Oral Proteins and Peptides Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Proteins and Peptides Forecast by Type (2026-2031)
12.7 Global Oral Proteins and Peptides Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Ironwood & Allergan
13.1.1 Ironwood & Allergan Company Information
13.1.2 Ironwood & Allergan Oral Proteins and Peptides Product Portfolios and Specifications
13.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Ironwood & Allergan Main Business Overview
13.1.5 Ironwood & Allergan Latest Developments
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Information
13.2.2 Novo Nordisk Oral Proteins and Peptides Product Portfolios and Specifications
13.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novo Nordisk Main Business Overview
13.2.5 Novo Nordisk Latest Developments
13.3 Synergy Pharmaceuticals ?Salix?
13.3.1 Synergy Pharmaceuticals ?Salix? Company Information
13.3.2 Synergy Pharmaceuticals ?Salix? Oral Proteins and Peptides Product Portfolios and Specifications
13.3.3 Synergy Pharmaceuticals ?Salix? Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Synergy Pharmaceuticals ?Salix? Main Business Overview
13.3.5 Synergy Pharmaceuticals ?Salix? Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Oral Proteins and Peptides Product Portfolios and Specifications
13.4.3 Novartis Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Chiasma (Amryt Pharma)
13.5.1 Chiasma (Amryt Pharma) Company Information
13.5.2 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolios and Specifications
13.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chiasma (Amryt Pharma) Main Business Overview
13.5.5 Chiasma (Amryt Pharma) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Proteins and Peptides Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oral Proteins and Peptides Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Linaclotide
Table 4. Major Players of Insulin
Table 5. Major Players of Plecanatide
Table 6. Major Players of Cyclosporine
Table 7. Major Players of Octreotide
Table 8. Global Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 9. Global Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Table 10. Global Oral Proteins and Peptides Revenue byType (2020-2025) & ($ million)
Table 11. Global Oral Proteins and Peptides Revenue Market Share byType (2020-2025)
Table 12. Global Oral Proteins and Peptides Sale Price byType (2020-2025) & (US$/Mg)
Table 13. Global Oral Proteins and Peptides Sale by Application (2020-2025) & (Kg)
Table 14. Global Oral Proteins and Peptides Sale Market Share by Application (2020-2025)
Table 15. Global Oral Proteins and Peptides Revenue by Application (2020-2025) & ($ million)
Table 16. Global Oral Proteins and Peptides Revenue Market Share by Application (2020-2025)
Table 17. Global Oral Proteins and Peptides Sale Price by Application (2020-2025) & (US$/Mg)
Table 18. Global Oral Proteins and Peptides Sales by Company (2020-2025) & (Kg)
Table 19. Global Oral Proteins and Peptides Sales Market Share by Company (2020-2025)
Table 20. Global Oral Proteins and Peptides Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Oral Proteins and Peptides Revenue Market Share by Company (2020-2025)
Table 22. Global Oral Proteins and Peptides Sale Price by Company (2020-2025) & (US$/Mg)
Table 23. Key Manufacturers Oral Proteins and Peptides Producing Area Distribution and Sales Area
Table 24. Players Oral Proteins and Peptides Products Offered
Table 25. Oral Proteins and Peptides Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Oral Proteins and Peptides Sales by Geographic Region (2020-2025) & (Kg)
Table 29. Global Oral Proteins and Peptides Sales Market Share Geographic Region (2020-2025)
Table 30. Global Oral Proteins and Peptides Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Oral Proteins and Peptides Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Oral Proteins and Peptides Sales by Country/Region (2020-2025) & (Kg)
Table 33. Global Oral Proteins and Peptides Sales Market Share by Country/Region (2020-2025)
Table 34. Global Oral Proteins and Peptides Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Oral Proteins and Peptides Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
Table 37. Americas Oral Proteins and Peptides Sales Market Share by Country (2020-2025)
Table 38. Americas Oral Proteins and Peptides Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 40. Americas Oral Proteins and Peptides Sales by Application (2020-2025) & (Kg)
Table 41. APAC Oral Proteins and Peptides Sales by Region (2020-2025) & (Kg)
Table 42. APAC Oral Proteins and Peptides Sales Market Share by Region (2020-2025)
Table 43. APAC Oral Proteins and Peptides Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 45. APAC Oral Proteins and Peptides Sales by Application (2020-2025) & (Kg)
Table 46. Europe Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
Table 47. Europe Oral Proteins and Peptides Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 49. Europe Oral Proteins and Peptides Sales by Application (2020-2025) & (Kg)
Table 50. Middle East & Africa Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
Table 51. Middle East & Africa Oral Proteins and Peptides Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 53. Middle East & Africa Oral Proteins and Peptides Sales by Application (2020-2025) & (Kg)
Table 54. Key Market Drivers & Growth Opportunities of Oral Proteins and Peptides
Table 55. Key Market Challenges & Risks of Oral Proteins and Peptides
Table 56. Key IndustryTrends of Oral Proteins and Peptides
Table 57. Oral Proteins and Peptides Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Oral Proteins and Peptides Distributors List
Table 60. Oral Proteins and Peptides Customer List
Table 61. Global Oral Proteins and Peptides SalesForecast by Region (2026-2031) & (Kg)
Table 62. Global Oral Proteins and Peptides RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Oral Proteins and Peptides SalesForecast by Country (2026-2031) & (Kg)
Table 64. Americas Oral Proteins and Peptides Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Oral Proteins and Peptides SalesForecast by Region (2026-2031) & (Kg)
Table 66. APAC Oral Proteins and Peptides Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Oral Proteins and Peptides SalesForecast by Country (2026-2031) & (Kg)
Table 68. Europe Oral Proteins and Peptides RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Oral Proteins and Peptides SalesForecast by Country (2026-2031) & (Kg)
Table 70. Middle East & Africa Oral Proteins and Peptides RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Oral Proteins and Peptides SalesForecast byType (2026-2031) & (Kg)
Table 72. Global Oral Proteins and Peptides RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Oral Proteins and Peptides SalesForecast by Application (2026-2031) & (Kg)
Table 74. Global Oral Proteins and Peptides RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. Ironwood & Allergan Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 76. Ironwood & Allergan Oral Proteins and Peptides Product Portfolios and Specifications
Table 77. Ironwood & Allergan Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 78. Ironwood & Allergan Main Business
Table 79. Ironwood & Allergan Latest Developments
Table 80. Novo Nordisk Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 81. Novo Nordisk Oral Proteins and Peptides Product Portfolios and Specifications
Table 82. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 83. Novo Nordisk Main Business
Table 84. Novo Nordisk Latest Developments
Table 85. Synergy Pharmaceuticals ?Salix? Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 86. Synergy Pharmaceuticals ?Salix? Oral Proteins and Peptides Product Portfolios and Specifications
Table 87. Synergy Pharmaceuticals ?Salix? Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 88. Synergy Pharmaceuticals ?Salix? Main Business
Table 89. Synergy Pharmaceuticals ?Salix? Latest Developments
Table 90. Novartis Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 91. Novartis Oral Proteins and Peptides Product Portfolios and Specifications
Table 92. Novartis Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 93. Novartis Main Business
Table 94. Novartis Latest Developments
Table 95. Chiasma (Amryt Pharma) Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 96. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolios and Specifications
Table 97. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 98. Chiasma (Amryt Pharma) Main Business
Table 99. Chiasma (Amryt Pharma) Latest Developments
Table 1. Oral Proteins and Peptides Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oral Proteins and Peptides Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Linaclotide
Table 4. Major Players of Insulin
Table 5. Major Players of Plecanatide
Table 6. Major Players of Cyclosporine
Table 7. Major Players of Octreotide
Table 8. Global Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 9. Global Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Table 10. Global Oral Proteins and Peptides Revenue byType (2020-2025) & ($ million)
Table 11. Global Oral Proteins and Peptides Revenue Market Share byType (2020-2025)
Table 12. Global Oral Proteins and Peptides Sale Price byType (2020-2025) & (US$/Mg)
Table 13. Global Oral Proteins and Peptides Sale by Application (2020-2025) & (Kg)
Table 14. Global Oral Proteins and Peptides Sale Market Share by Application (2020-2025)
Table 15. Global Oral Proteins and Peptides Revenue by Application (2020-2025) & ($ million)
Table 16. Global Oral Proteins and Peptides Revenue Market Share by Application (2020-2025)
Table 17. Global Oral Proteins and Peptides Sale Price by Application (2020-2025) & (US$/Mg)
Table 18. Global Oral Proteins and Peptides Sales by Company (2020-2025) & (Kg)
Table 19. Global Oral Proteins and Peptides Sales Market Share by Company (2020-2025)
Table 20. Global Oral Proteins and Peptides Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Oral Proteins and Peptides Revenue Market Share by Company (2020-2025)
Table 22. Global Oral Proteins and Peptides Sale Price by Company (2020-2025) & (US$/Mg)
Table 23. Key Manufacturers Oral Proteins and Peptides Producing Area Distribution and Sales Area
Table 24. Players Oral Proteins and Peptides Products Offered
Table 25. Oral Proteins and Peptides Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Oral Proteins and Peptides Sales by Geographic Region (2020-2025) & (Kg)
Table 29. Global Oral Proteins and Peptides Sales Market Share Geographic Region (2020-2025)
Table 30. Global Oral Proteins and Peptides Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Oral Proteins and Peptides Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Oral Proteins and Peptides Sales by Country/Region (2020-2025) & (Kg)
Table 33. Global Oral Proteins and Peptides Sales Market Share by Country/Region (2020-2025)
Table 34. Global Oral Proteins and Peptides Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Oral Proteins and Peptides Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
Table 37. Americas Oral Proteins and Peptides Sales Market Share by Country (2020-2025)
Table 38. Americas Oral Proteins and Peptides Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 40. Americas Oral Proteins and Peptides Sales by Application (2020-2025) & (Kg)
Table 41. APAC Oral Proteins and Peptides Sales by Region (2020-2025) & (Kg)
Table 42. APAC Oral Proteins and Peptides Sales Market Share by Region (2020-2025)
Table 43. APAC Oral Proteins and Peptides Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 45. APAC Oral Proteins and Peptides Sales by Application (2020-2025) & (Kg)
Table 46. Europe Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
Table 47. Europe Oral Proteins and Peptides Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 49. Europe Oral Proteins and Peptides Sales by Application (2020-2025) & (Kg)
Table 50. Middle East & Africa Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
Table 51. Middle East & Africa Oral Proteins and Peptides Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Oral Proteins and Peptides Sales byType (2020-2025) & (Kg)
Table 53. Middle East & Africa Oral Proteins and Peptides Sales by Application (2020-2025) & (Kg)
Table 54. Key Market Drivers & Growth Opportunities of Oral Proteins and Peptides
Table 55. Key Market Challenges & Risks of Oral Proteins and Peptides
Table 56. Key IndustryTrends of Oral Proteins and Peptides
Table 57. Oral Proteins and Peptides Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Oral Proteins and Peptides Distributors List
Table 60. Oral Proteins and Peptides Customer List
Table 61. Global Oral Proteins and Peptides SalesForecast by Region (2026-2031) & (Kg)
Table 62. Global Oral Proteins and Peptides RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Oral Proteins and Peptides SalesForecast by Country (2026-2031) & (Kg)
Table 64. Americas Oral Proteins and Peptides Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Oral Proteins and Peptides SalesForecast by Region (2026-2031) & (Kg)
Table 66. APAC Oral Proteins and Peptides Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Oral Proteins and Peptides SalesForecast by Country (2026-2031) & (Kg)
Table 68. Europe Oral Proteins and Peptides RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Oral Proteins and Peptides SalesForecast by Country (2026-2031) & (Kg)
Table 70. Middle East & Africa Oral Proteins and Peptides RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Oral Proteins and Peptides SalesForecast byType (2026-2031) & (Kg)
Table 72. Global Oral Proteins and Peptides RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Oral Proteins and Peptides SalesForecast by Application (2026-2031) & (Kg)
Table 74. Global Oral Proteins and Peptides RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. Ironwood & Allergan Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 76. Ironwood & Allergan Oral Proteins and Peptides Product Portfolios and Specifications
Table 77. Ironwood & Allergan Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 78. Ironwood & Allergan Main Business
Table 79. Ironwood & Allergan Latest Developments
Table 80. Novo Nordisk Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 81. Novo Nordisk Oral Proteins and Peptides Product Portfolios and Specifications
Table 82. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 83. Novo Nordisk Main Business
Table 84. Novo Nordisk Latest Developments
Table 85. Synergy Pharmaceuticals ?Salix? Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 86. Synergy Pharmaceuticals ?Salix? Oral Proteins and Peptides Product Portfolios and Specifications
Table 87. Synergy Pharmaceuticals ?Salix? Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 88. Synergy Pharmaceuticals ?Salix? Main Business
Table 89. Synergy Pharmaceuticals ?Salix? Latest Developments
Table 90. Novartis Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 91. Novartis Oral Proteins and Peptides Product Portfolios and Specifications
Table 92. Novartis Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 93. Novartis Main Business
Table 94. Novartis Latest Developments
Table 95. Chiasma (Amryt Pharma) Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 96. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolios and Specifications
Table 97. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 98. Chiasma (Amryt Pharma) Main Business
Table 99. Chiasma (Amryt Pharma) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral Proteins and Peptides
Figure 2. Oral Proteins and Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Proteins and Peptides Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Oral Proteins and Peptides Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oral Proteins and Peptides Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oral Proteins and Peptides Sales Market Share by Country/Region (2024)
Figure 10. Oral Proteins and Peptides Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Linaclotide
Figure 12. Product Picture of Insulin
Figure 13. Product Picture of Plecanatide
Figure 14. Product Picture of Cyclosporine
Figure 15. Product Picture of Octreotide
Figure 16. Global Oral Proteins and Peptides Sales Market Share byType in 2025
Figure 17. Global Oral Proteins and Peptides Revenue Market Share byType (2020-2025)
Figure 18. Oral Proteins and Peptides Consumed in Gastric & Digestive Disorders
Figure 19. Global Oral Proteins and Peptides Market: Gastric & Digestive Disorders (2020-2025) & (Kg)
Figure 20. Oral Proteins and Peptides Consumed in Bone Diseases
Figure 21. Global Oral Proteins and Peptides Market: Bone Diseases (2020-2025) & (Kg)
Figure 22. Oral Proteins and Peptides Consumed in Diabetes
Figure 23. Global Oral Proteins and Peptides Market: Diabetes (2020-2025) & (Kg)
Figure 24. Oral Proteins and Peptides Consumed in Hormonal Disorders
Figure 25. Global Oral Proteins and Peptides Market: Hormonal Disorders (2020-2025) & (Kg)
Figure 26. Global Oral Proteins and Peptides Sale Market Share by Application (2024)
Figure 27. Global Oral Proteins and Peptides Revenue Market Share by Application in 2025
Figure 28. Oral Proteins and Peptides Sales by Company in 2025 (Kg)
Figure 29. Global Oral Proteins and Peptides Sales Market Share by Company in 2025
Figure 30. Oral Proteins and Peptides Revenue by Company in 2025 ($ millions)
Figure 31. Global Oral Proteins and Peptides Revenue Market Share by Company in 2025
Figure 32. Global Oral Proteins and Peptides Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Oral Proteins and Peptides Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Oral Proteins and Peptides Sales 2020-2025 (Kg)
Figure 35. Americas Oral Proteins and Peptides Revenue 2020-2025 ($ millions)
Figure 36. APAC Oral Proteins and Peptides Sales 2020-2025 (Kg)
Figure 37. APAC Oral Proteins and Peptides Revenue 2020-2025 ($ millions)
Figure 38. Europe Oral Proteins and Peptides Sales 2020-2025 (Kg)
Figure 39. Europe Oral Proteins and Peptides Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Oral Proteins and Peptides Sales 2020-2025 (Kg)
Figure 41. Middle East & Africa Oral Proteins and Peptides Revenue 2020-2025 ($ millions)
Figure 42. Americas Oral Proteins and Peptides Sales Market Share by Country in 2025
Figure 43. Americas Oral Proteins and Peptides Revenue Market Share by Country (2020-2025)
Figure 44. Americas Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Figure 45. Americas Oral Proteins and Peptides Sales Market Share by Application (2020-2025)
Figure 46. United States Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Oral Proteins and Peptides Sales Market Share by Region in 2025
Figure 51. APAC Oral Proteins and Peptides Revenue Market Share by Region (2020-2025)
Figure 52. APAC Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Figure 53. APAC Oral Proteins and Peptides Sales Market Share by Application (2020-2025)
Figure 54. China Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 58. India Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Oral Proteins and Peptides Sales Market Share by Country in 2025
Figure 62. Europe Oral Proteins and Peptides Revenue Market Share by Country (2020-2025)
Figure 63. Europe Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Figure 64. Europe Oral Proteins and Peptides Sales Market Share by Application (2020-2025)
Figure 65. Germany Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 66.France Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Application (2020-2025)
Figure 73. Egypt Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Oral Proteins and Peptides in 2025
Figure 79. Manufacturing Process Analysis of Oral Proteins and Peptides
Figure 80. Industry Chain Structure of Oral Proteins and Peptides
Figure 81. Channels of Distribution
Figure 82. Global Oral Proteins and Peptides Sales MarketForecast by Region (2026-2031)
Figure 83. Global Oral Proteins and Peptides Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Oral Proteins and Peptides Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Oral Proteins and Peptides Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Oral Proteins and Peptides Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Oral Proteins and Peptides Revenue Market ShareForecast by Application (2026-2031)
Figure 1. Picture of Oral Proteins and Peptides
Figure 2. Oral Proteins and Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Proteins and Peptides Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Oral Proteins and Peptides Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oral Proteins and Peptides Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oral Proteins and Peptides Sales Market Share by Country/Region (2024)
Figure 10. Oral Proteins and Peptides Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Linaclotide
Figure 12. Product Picture of Insulin
Figure 13. Product Picture of Plecanatide
Figure 14. Product Picture of Cyclosporine
Figure 15. Product Picture of Octreotide
Figure 16. Global Oral Proteins and Peptides Sales Market Share byType in 2025
Figure 17. Global Oral Proteins and Peptides Revenue Market Share byType (2020-2025)
Figure 18. Oral Proteins and Peptides Consumed in Gastric & Digestive Disorders
Figure 19. Global Oral Proteins and Peptides Market: Gastric & Digestive Disorders (2020-2025) & (Kg)
Figure 20. Oral Proteins and Peptides Consumed in Bone Diseases
Figure 21. Global Oral Proteins and Peptides Market: Bone Diseases (2020-2025) & (Kg)
Figure 22. Oral Proteins and Peptides Consumed in Diabetes
Figure 23. Global Oral Proteins and Peptides Market: Diabetes (2020-2025) & (Kg)
Figure 24. Oral Proteins and Peptides Consumed in Hormonal Disorders
Figure 25. Global Oral Proteins and Peptides Market: Hormonal Disorders (2020-2025) & (Kg)
Figure 26. Global Oral Proteins and Peptides Sale Market Share by Application (2024)
Figure 27. Global Oral Proteins and Peptides Revenue Market Share by Application in 2025
Figure 28. Oral Proteins and Peptides Sales by Company in 2025 (Kg)
Figure 29. Global Oral Proteins and Peptides Sales Market Share by Company in 2025
Figure 30. Oral Proteins and Peptides Revenue by Company in 2025 ($ millions)
Figure 31. Global Oral Proteins and Peptides Revenue Market Share by Company in 2025
Figure 32. Global Oral Proteins and Peptides Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Oral Proteins and Peptides Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Oral Proteins and Peptides Sales 2020-2025 (Kg)
Figure 35. Americas Oral Proteins and Peptides Revenue 2020-2025 ($ millions)
Figure 36. APAC Oral Proteins and Peptides Sales 2020-2025 (Kg)
Figure 37. APAC Oral Proteins and Peptides Revenue 2020-2025 ($ millions)
Figure 38. Europe Oral Proteins and Peptides Sales 2020-2025 (Kg)
Figure 39. Europe Oral Proteins and Peptides Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Oral Proteins and Peptides Sales 2020-2025 (Kg)
Figure 41. Middle East & Africa Oral Proteins and Peptides Revenue 2020-2025 ($ millions)
Figure 42. Americas Oral Proteins and Peptides Sales Market Share by Country in 2025
Figure 43. Americas Oral Proteins and Peptides Revenue Market Share by Country (2020-2025)
Figure 44. Americas Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Figure 45. Americas Oral Proteins and Peptides Sales Market Share by Application (2020-2025)
Figure 46. United States Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Oral Proteins and Peptides Sales Market Share by Region in 2025
Figure 51. APAC Oral Proteins and Peptides Revenue Market Share by Region (2020-2025)
Figure 52. APAC Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Figure 53. APAC Oral Proteins and Peptides Sales Market Share by Application (2020-2025)
Figure 54. China Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 58. India Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Oral Proteins and Peptides Sales Market Share by Country in 2025
Figure 62. Europe Oral Proteins and Peptides Revenue Market Share by Country (2020-2025)
Figure 63. Europe Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Figure 64. Europe Oral Proteins and Peptides Sales Market Share by Application (2020-2025)
Figure 65. Germany Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 66.France Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Oral Proteins and Peptides Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Application (2020-2025)
Figure 73. Egypt Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Oral Proteins and Peptides Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Oral Proteins and Peptides in 2025
Figure 79. Manufacturing Process Analysis of Oral Proteins and Peptides
Figure 80. Industry Chain Structure of Oral Proteins and Peptides
Figure 81. Channels of Distribution
Figure 82. Global Oral Proteins and Peptides Sales MarketForecast by Region (2026-2031)
Figure 83. Global Oral Proteins and Peptides Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Oral Proteins and Peptides Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Oral Proteins and Peptides Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Oral Proteins and Peptides Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Oral Proteins and Peptides Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Recombinant Trypsin Liquid Solution Market Growth 2024-2030
US$ 3,660.00
March 2024
111 pages
Global Interleukin 6 Quantitative Determination Kit Market Growth 2024-2030
US$ 3,660.00
September 2024
75 pages
Global Handheld DNA Readers Market Growth 2023-2029
US$ 3,660.00
March 2023
73 pages
Global Drugs of Ursodeoxycholic Acid Market Growth 2024-2030
US$ 3,660.00
March 2024
114 pages
Global Extracorporeal Lithotripsy Market Growth 2024-2030
US$ 3,660.00
March 2024
137 pages
